Phase 4 Parkinson's Disease Clinical Trials
5 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–5 of 5 trials
Recruiting
Phase 4
Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease
InsomniaParkinson's DiseaseMotor Disorder
YangPan44 enrolled1 locationNCT07384429
Recruiting
Phase 4
Comparing Antipsychotic Medications in LBD Over Time
Dementia With Lewy BodiesParkinson's Disease Psychosis
The University of Texas Health Science Center at San Antonio94 enrolled2 locationsNCT05590637
Recruiting
Phase 4
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Parkinson's Disease Psychosis
VA Office of Research and Development358 enrolled24 locationsNCT04373317
Recruiting
Phase 4
The effect of a GLP-1 agonist in patients with a dual diagnosis of Parkinson's Disease and Type 2 Diabetes Mellitus
Type 2 Diabetes MellitusParkinson's Disease
St Vincent's Health Network12 enrolled1 locationACTRN12620000627954
Not Yet Recruiting
Phase 4
Using N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson’s Disease
InsomniaParkinson's Disease
University of Queensland44 enrolled1 locationACTRN12617001103358